Published in J Clin Microbiol on August 01, 1986
Overview of medically important antifungal azole derivatives. Clin Microbiol Rev (1988) 3.33
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol (1998) 1.89
Improved method for azole antifungal susceptibility testing. J Clin Microbiol (1988) 1.86
Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing. J Clin Microbiol (1988) 1.71
Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol (2001) 1.68
In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method. Antimicrob Agents Chemother (1992) 1.09
Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media. J Clin Microbiol (1993) 1.03
Entry of five antifungal agents into the ovine lung. Antimicrob Agents Chemother (1987) 0.76
In vitro studies with 5-fluorocytosine. Appl Microbiol (1969) 8.01
Culture of the urine. J Lab Clin Med (1960) 5.61
Analysis of pH and buffer effects on flucytosine activity in broth dilution susceptibility testing of Candida albicans in two synthetic media. Antimicrob Agents Chemother (1984) 3.74
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31
Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09
Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans. Antimicrob Agents Chemother (1984) 1.88
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. J Clin Microbiol (1984) 1.67
Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species. J Antimicrob Chemother (1983) 1.41
[Clinical and experimental studies on antimycotics]. Arzneimittelforschung (1953) 1.30
In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother (1984) 0.94
Chemotherapy of the systemic mycoses. Med Clin North Am (1982) 0.88
Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60
Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47
Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40
Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43
Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31
Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23
Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09
Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83
Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81
Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74
Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57
Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52
Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50
Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44
Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39
Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38
Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36
Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36
Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35
Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32
Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31
An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27
Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23
Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20
Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20
Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18
Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17
Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17
Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother (1980) 1.16
Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother (1977) 1.15
Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10
Treatment of open fractures: a prospective study. J Trauma (1983) 1.10
Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08
Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1969) 1.05
Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05
Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03
Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01
Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis (1976) 1.00
Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med (1967) 0.99
Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry (1983) 0.98
Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med (1981) 0.98
The polymyxins. Med Clin North Am (1970) 0.97
Grouping of gram-negative bacteria and susceptibility to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.94
In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother (1984) 0.94
Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med (1982) 0.94
Adverse influence of ozone on pulmonary bactericidal activity of murine lung. Nature (1971) 0.94
Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.93
Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem (1985) 0.91
Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91
Providence bacillus bacteremia and septicopyemia. Am J Med (1968) 0.91
Purification of High Titer Tetanus Toxin. J Bacteriol (1945) 0.90
Reproducible method for induction of pulmonary coccidioidomycosis in mice. J Infect Dis (1977) 0.90
Recovery from encephalomyelitis caused by Herpesvirus simiae. Report of a case. Arch Intern Med (1975) 0.88
Parenteral sodium ampicillin therapy of endocarditis, salmonellosis, and other bacterial infections. Antimicrob Agents Chemother (Bethesda) (1965) 0.88
Ozone and the antibacterial defense mechanisms of the murine lung. Arch Intern Med (1971) 0.88
In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 0.88
Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis (1992) 0.88
Shigellemia. West J Med (1984) 0.87
Reliability of a commercial triphenyltetrazolium chloride reduction test for detecting significant bacteriuria. Am J Med Sci (1966) 0.87
Entry of four cephalosporins into the ovine lung. J Infect Dis (1984) 0.87
Etiologic diagnosis of lower respiratory tract infections. Calif Med (1970) 0.86
Cold sterilization of ureteral catheters with ethylene oxide gas. J Urol (1966) 0.86
Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Proc Natl Acad Sci U S A (1991) 0.85
Entry of four tetracyclines into saliva and tears. Antimicrob Agents Chemother (1974) 0.85
In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species. Antimicrob Agents Chemother (1973) 0.84
Toxicity of amphotericins on chronic administration to mongrel dogs. Diagn Microbiol Infect Dis (1985) 0.84
The penicillins, old and new. Review and perspectives. Calif Med (1968) 0.83
New antifungal drugs in the therapy of systemic mycoses. Scand J Infect Dis Suppl (1978) 0.82
Analysis of bacterial isolates from cerebrospinal fluid. J Clin Microbiol (1984) 0.81
A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. J Biol Chem (1985) 0.81
Engulfment and bactericidal capabilities of peripheral blood leukocytes in chronic leukemias. Cancer (1969) 0.81
Quantitative microbiology of traumatic orthopedic wounds. J Clin Microbiol (1978) 0.80
Influence of culture media on the antistaphylococcal activity of fosfomycin. Appl Microbiol (1971) 0.80
The effects of anesthetic agents on murine pulmonary bactericidal activity. Anesthesiology (1971) 0.80
Cellular receptors to the anaphylatoxins C3a and C5a. Biochem Soc Symp (1986) 0.79
Effect of recombinant human interleukin 2 in experimental murine coccidioidomycosis. Diagn Microbiol Infect Dis (1988) 0.79
Typhoid fever caused by chloramphenicol-resistant organisms. JAMA (1973) 0.79
Diagnostic value of gallium and bone scans in evaluation of extrapulmonary coccidioidal lesions. Am Rev Respir Dis (1980) 0.79
Antifungal chemotherapy. Prog Drug Res (1995) 0.78
Effect of cycloserines on D-amino acid oxidase. Arch Biochem Biophys (1966) 0.77
New antimicrobics for the treatment of infections caused by gram-negative bacilli. Med Clin North Am (1967) 0.77
Influence of anesthetic agents on murine pulmonary bactericidal activity. Antimicrob Agents Chemother (Bethesda) (1970) 0.77
Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis. Eur J Clin Microbiol (1985) 0.76
Helical conformation at the carboxy-terminal portion of human C3a is required for full activity. Biochemistry (1986) 0.76
Treatment of coccidioidomycosis with miconazole. JAMA (1980) 0.76
The changing face of pneumonia. Hosp Pract (1979) 0.76
Effect of vitamin E and ozone on the pulmonary antibacterial defense mechanisms. J Lab Clin Med (1974) 0.76
Bioactive complement fragments in immunoregulation. Immunol Lett (1985) 0.76
Tracheobronchial flora in chronic obstructive pulmonary disease: preliminary results with authentic specimens and trial of trimethoprim-sulfamethoxazole. J Infect Dis (1973) 0.76
Entry of five antifungal agents into the ovine lung. Antimicrob Agents Chemother (1987) 0.76
Illicit intravenous drug use and bacterial endocarditis. Calif Med (1973) 0.75
Totally synthetic medium for susceptibility testing. Antimicrob Agents Chemother (1978) 0.75